These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6795743)

  • 1. High frequency of low plasma haptoglobin values found in hemophilia A patients on prophylactic treatment with factor VIII concentrates - a sign of hemolysis?
    Egberg N; Blombäck M
    Thromb Haemost; 1981 Aug; 46(2):554-7. PubMed ID: 6795743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced serum haptoglobin values in hemophiliacs receiving monoclonally purified factor VIII concentrates.
    Buchanan GR; Holtkamp CA; Johnson A
    Am J Hematol; 1990 Apr; 33(4):234-7. PubMed ID: 2107738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
    de Biasi R; Rocino A; Papa ML; Salerno E; Mastrullo L; De Blasi D
    Thromb Haemost; 1994 May; 71(5):544-7. PubMed ID: 8091377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma haptoglobin and alpha-2-macroglobulin in hemophiliacs receiving factor replacement therapy.
    Shulman G; Ballard JO; Eyster ME
    Am J Hematol; 1985 Mar; 18(3):223-33. PubMed ID: 2579546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the levels of anti-A, anti-B isoagglutinin titer in various kinds of concentrates for hemophilia treatment--with special regard to the manufacturing process of factor VIII concentrate].
    Tomita Y; Inagaki M; Taki M; Miura T; Saito N; Sato R; Meguro T; Yamada K
    Rinsho Ketsueki; 1985 Feb; 26(2):166-70. PubMed ID: 3927035
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of clinical factors on the haemolysis marker haptoglobin.
    Körmöczi GF; Säemann MD; Buchta C; Peck-Radosavljevic M; Mayr WR; Schwartz DW; Dunkler D; Spitzauer S; Panzer S
    Eur J Clin Invest; 2006 Mar; 36(3):202-9. PubMed ID: 16506966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolysis caused by factor VIII concentrates.
    Orringer EP; Koury MJ; Blatt PM; Roberts HR
    Arch Intern Med; 1976 Sep; 136(9):1018-20. PubMed ID: 962445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of factor VIII concentrates on the immune system of patients with hemophilia.
    Mannucci PM
    Thromb Haemost; 1995 Jul; 74(1):437-9. PubMed ID: 8578501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of factor VIII concentrates of very high purity on CD4+ cell count in hemophiliacs infected with HIV].
    Molina Alejandro R; Lorenzo Herrero JI; Haya Guaita S; Querol Fuentes F; Aznar Lucea JA
    Rev Clin Esp; 1996 Jun; 196(6):365-9. PubMed ID: 8767071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.
    Sabin C; Pasi J; Phillips A; Elford J; Janossy G; Lee C
    Thromb Haemost; 1994 Aug; 72(2):214-7. PubMed ID: 7831654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal serum transaminase levels in patients with hemophilia A.
    Cederbaum AI; Blatt PM; Levine PH
    Arch Intern Med; 1982 Mar; 142(3):481-4. PubMed ID: 6802093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
    Gaboulaud V; Parquet A; Tahiri C; Claeyssens S; Potard V; Faradji A; Peynet J; Costagliola D;
    Br J Haematol; 2002 Feb; 116(2):383-9. PubMed ID: 11841442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin level in haemophiliacs after administration of pooled cold precipitated antihaemophilic globulin. Preliminary report.
    Veselý V; Kulich V
    Haematologia (Budap); 1976; 10(3-4):379-81. PubMed ID: 1028672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates.
    von Auer Ch; Oldenburg J; von Depka M; Escuriola-Ettinghausen C; Kurnik K; Lenk H; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1051():498-505. PubMed ID: 16126990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).
    Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R
    Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired hemophilia. Apropos of a case report with a fatal course].
    de Moerloose P; Tissot JD; Reber G; Schifferli J; Vogel J; Bouvier CA
    Schweiz Med Wochenschr; 1988 Oct; 118(42):1542-5. PubMed ID: 3144037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.